| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ALEXION PHARMACEUTIC | 121,000 | 16,846,000 | 3.34% | ||
| 2 | GILEAD SCIENCES INC | 180,000 | 16,535,000 | 3.28% | ||
| 3 | BIOMARIN | 190,000 | 15,671,000 | 3.11% | ||
| 4 | PFIZER INC | 475,000 | 14,079,000 | 2.79% | ||
| 5 | LILLY ELI & CO | 195,000 | 14,042,000 | 2.79% | ||
| 6 | ALKERMES PLC SHS | 405,000 | 13,847,000 | 2.75% | ||
| 7 | INCYTE | 170,000 | 12,320,000 | 2.45% | ||
| 8 | CELGENE CORP | 120,000 | 12,011,000 | 2.38% | ||
| 9 | ABIOMED INC | 125,000 | 11,851,000 | 2.35% | ||
| 10 | ALLERGAN PLC | 42,000 | 11,257,000 | 2.23% | ||
| 11 | CVS HEALTH CORP | 105,000 | 10,892,000 | 2.16% | ||
| 12 | MEDTRONIC PLC | 137,000 | 10,275,000 | 2.04% | ||
| 13 | ST JUDE | 180,000 | 9,900,000 | 1.97% | ||
| 14 | BIOGEN INC | 38,000 | 9,892,000 | 1.96% | ||
| 15 | ZIMMER BIOMET HLDGS INC | 91,000 | 9,703,000 | 1.93% | ||
| 16 | CIGNA CORPORATION | 69,000 | 9,470,000 | 1.88% | ||
| 17 | BRISTOL MYERS SQUIBB CO | 142,000 | 9,071,000 | 1.80% | ||
| 18 | LABORATORY CORP AMER HLDGS | 75,000 | 8,785,000 | 1.74% | ||
| 19 | CENTENE CORP DEL | 141,712 | 8,725,000 | 1.73% | ||
| 20 | MEDIVATION INC | 187,000 | 8,598,000 | 1.71% | ||
| 21 | WALGREENS BOOTS ALLIANCE INC | 100,000 | 8,424,000 | 1.67% | ||
| 22 | HCA HOLDINGS INC | 104,000 | 8,117,000 | 1.61% | ||
| 23 | ALNYLAM PHARMACEUTICALS INC | 125,000 | 7,846,000 | 1.56% | ||
| 24 | PERRIGO CO PLC | 61,000 | 7,804,000 | 1.55% | ||
| 25 | UNITEDHEALTH GROUP INC | 60,000 | 7,734,000 | 1.54% | ||
| 26 | CARDINAL HEALTH INC | 92,000 | 7,539,000 | 1.50% | ||
| 27 | AETNA INC NEW | 67,000 | 7,527,000 | 1.49% | ||
| 28 | ABBVIE INC | 130,000 | 7,426,000 | 1.47% | ||
| 29 | ENDO INTL | 260,000 | 7,319,000 | 1.45% | ||
| 30 | EXPRESS SCRIPTS HLDG CO | 106,000 | 7,281,000 | 1.45% | ||
| 31 | NEKTAR THERAPEUTICS COM | 525,000 | 7,219,000 | 1.43% | ||
| 32 | AMGEN INC | 45,000 | 6,747,000 | 1.34% | ||
| 33 | ANTHEM INC | 47,000 | 6,533,000 | 1.30% | ||
| 34 | MCKESSON CORP | 40,000 | 6,290,000 | 1.25% | ||
| 35 | VERTEX PHARMACEUT | 78,000 | 6,200,000 | 1.23% | ||
| 36 | COOPER COS INC | 40,000 | 6,159,000 | 1.22% | ||
| 37 | CENCORA | 63,000 | 5,453,000 | 1.08% | ||
| 38 | DEXCOM | 75,000 | 5,093,000 | 1.01% | ||
| 39 | CEPHEID | 150,000 | 5,004,000 | 0.99% | ||
| 40 | HUMANA | 27,000 | 4,940,000 | 0.98% | ||
| 41 | EDWARDS LIFESCIENCES CORP | 55,000 | 4,852,000 | 0.96% | ||
| 42 | CERNER CORP | 86,000 | 4,555,000 | 0.90% | ||
| 43 | KERYX BIOPHARMACEUTICALS INCORPORATED | 950,000 | 4,437,000 | 0.88% | ||
| 44 | ZELTIQ AESTHETICS INCORPORATED | 160,000 | 4,346,000 | 0.86% | ||
| 45 | REGENERON PHARMACEUTICALS | 12,000 | 4,325,000 | 0.86% | ||
| 46 | COMMUNITY HEALTH SYS INC NEW COM | 225,000 | 4,165,000 | 0.83% | ||
| 47 | SUPERNUS PHARMACEUTICALS INC COM | 270,000 | 4,118,000 | 0.82% | ||
| 48 | HALOZYME THERAPEUTICS INC | 431,000 | 4,082,000 | 0.81% | ||
| 49 | JAZZ PHARMACEUTICALS PLC SHS USD | 30,000 | 3,917,000 | 0.78% | ||
| 50 | ARIAD PHARMACEUTICALS INC | 600,000 | 3,834,000 | 0.76% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001415889-16-005562, filed 2016.04.19).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
